SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001214659-24-004701
Filing Date
2024-03-18
Accepted
2024-03-18 16:31:52
Documents
152

Document Format Files

Seq Description Document Type Size
1 j311241f1.htm   iXBRL F-1 4277176
2 EXHIBIT 4.1 ex4_1.htm EX-4.1 315015
3 EXHIBIT 5.1 ex5_1.htm EX-5.1 67955
4 EXHIBIT 21.1 ex21_1.htm EX-21.1 7052
5 EXHIBIT 23.1 ex23_1.htm EX-23.1 8582
6 EXHIBIT 107 ex107.htm EX-FILING FEES 11200
12 GRAPHIC biodexa_logo.jpg GRAPHIC 13595
13 GRAPHIC chart1.jpg GRAPHIC 89524
14 GRAPHIC mazars_logomed.jpg GRAPHIC 10264
  Complete submission text file 0001214659-24-004701.txt   16714662

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE bdrx-20230630.xsd EX-101.SCH 129242
8 XBRL CALCULATION FILE bdrx-20230630_cal.xml EX-101.CAL 81636
9 XBRL DEFINITION FILE bdrx-20230630_def.xml EX-101.DEF 313831
10 XBRL LABEL FILE bdrx-20230630_lab.xml EX-101.LAB 530965
11 XBRL PRESENTATION FILE bdrx-20230630_pre.xml EX-101.PRE 498940
155 EXTRACTED XBRL INSTANCE DOCUMENT j311241f1_htm.xml XML 3594980
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-278040 | Film No.: 24759512
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)